[Pharmacoeconomic Comparison Between Dupilumab and Tralokinumab for the Treatment of Atopic Dermatitis in Italy: A Cost-per-Responder Analysis]. (2025). Farmeconomia. Health Economics and Therapeutic Pathways, 26(1). https://doi.org/10.7175/fe.v26i1.1571